Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
CRML enters this week with a borrow market so tight it is effectively closed, a short position that has grown by 15% in a month, and a stock that has lost 11% over the past week, making it one of the most charged setups in the small-cap mining space right now.
The lending side of the story is the sharpest signal. Availability has collapsed to just 0.02% of the short position, meaning the lending pool is essentially exhausted. That compares to 10.8% a week ago, a drop of more than 80% in five sessions. Cost to borrow has more than tripled over the past month to 74.7%, and has been running in the 60s and 70s most of October after spending September in the 20s. The short interest itself stands at 26.7% of free float, up from roughly 22.5% a month ago, with short sellers having built steadily through late September. With availability this thin and borrow costs this high, new short positions are expensive to open and existing ones are costly to hold.
Options positioning offers almost no additional colour. The put/call ratio of 0.55 is barely above its 20-day average and well within a normal range for this stock, with a z-score of just 0.4. The 52-week band runs from 0.26 to 0.78, and the current reading is squarely in the middle. Options traders are not visibly piling into downside protection, a notable contrast with the aggression in the equity lending market.
The ORTEX short score of 85.5, ranking in the bottom 1st percentile of the universe on a per-share basis, captures how extreme the setup has become. Fundamental scores offer little relief: quality metrics are deeply negative, with a return on assets of -17.4% and an F-Score of just 1. The sole analyst in the consensus, from Freedom Broker, downgraded from Buy to Hold in August and cut the target from $17 to $8, noting this data is now 64 days old. With the stock at $6.54, even that reduced target implies meaningful distance to cover. Cantor Fitzgerald initiated with a Speculative Buy at $18 in July, but that figure looks difficult to reconcile with the current price and fundamental backdrop, so treat those targets as directional colour rather than precise anchors.
The ownership picture adds one more layer. European Lithium Limited holds 37.3% of shares under a Schedule 13D/A filing, making it an activist on the register in the formal SEC sense. Gregory Bennett Barnes filed a separate Schedule 13D disclosing 11.5% in May. Two 13D activists collectively controlling nearly half the float is unusual, and their presence constrains the effective free float considerably. That structural tightness in the float is part of why the lending pool is so thin. ORTEX's Index Rebalance Radar also flags an 84% probability of a share-count increase within the Russell 2000 and Russell 3000 at the December rebalance, tied to the agreed European Lithium takeover, with estimated trade dates of December 30 and effective dates of December 31. These are forecasts, not announcements, and the dates are ORTEX estimates rather than confirmed by the index provider.
Earnings history is worth a brief note. Three of the last four prints produced next-day declines averaging around 7%, with five-day moves ranging from -12% to -14% in the two most recent cases. The next scheduled event is December 11. How the borrow market and activist ownership structure interact with that catalyst, given availability near zero and two Schedule 13D holders on the register, is the most concrete thing to watch between now and year-end.
See the live data behind this article on ORTEX.
Open CRML on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
